Related Experiment Videos
[Immune granulocytopenia in children]
1Institut für Klinische Immunologie und Transfusionsmedizin, Justus-Liebig-Universität Giessen.
Klinische Padiatrie
|November 1, 1989
Summary
Immune neutropenia in infancy, caused by granulocyte-specific antibodies, affects young children. While often self-limiting, severe cases may require immunoglobulin or corticoid therapy.
Area of Science:
- Pediatric Hematology
- Immunology
Context:
- Immune neutropenia in infancy encompasses alloimmune and autoimmune forms.
- Both conditions stem from granulocyte-specific antibodies.
- Affected individuals are typically newborns and children under three years old.
Purpose:
- To describe the characteristics, diagnosis, and management of immune neutropenia in infancy.
Summary:
- Neutropenia in infants often results in recurrent, mild bacterial infections.
- Diagnosis involves blood counts, bone-marrow smears, and demonstrating granulocyte-specific antibodies.
- Management is typically conservative, with intravenous immunoglobulin or corticoid therapy for severe cases.
Impact:
- Provides a concise overview of infantile immune neutropenia for clinicians.
- Highlights diagnostic markers and therapeutic strategies.
- Emphasizes the generally self-limiting nature of the condition.